⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHAR News
Pharming Group N.V. ADS, each representing 10 ordinary shares
Bronstein, Gewirtz & Grossman, LLC Encourages Pharming Group N.V. (PHAR) Investors to Inquire about Securities Investigation
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pharming Group N.V. (PHAR) And Encourages Investors to Reach Out
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
prnewswire.com
PHAR
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pharming Group N.V. (PHAR) And Encourages Stockholders to Reach Out
accessnewswire.com
PHAR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
accessnewswire.com
PHAR
Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
globenewswire.com
PHARM
PHAR
Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS
globenewswire.com
PHARM
PHAR